A dose-response model for statistical analysis of chemical genetic interactions in CRISPRi screens.
An important application of CRISPR interference (CRISPRi) technology is for identifying chemical-genetic interactions (CGIs). Discovery of genes that interact with exposure to antibiotics can yield insights to drug targets and mechanisms of action or resistance. The objective is to identify CRISPRi...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-05-01
|
| Series: | PLoS Computational Biology |
| Online Access: | https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1011408&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846128232729935872 |
|---|---|
| author | Sanjeevani Choudhery Michael A DeJesus Aarthi Srinivasan Jeremy Rock Dirk Schnappinger Thomas R Ioerger |
| author_facet | Sanjeevani Choudhery Michael A DeJesus Aarthi Srinivasan Jeremy Rock Dirk Schnappinger Thomas R Ioerger |
| author_sort | Sanjeevani Choudhery |
| collection | DOAJ |
| description | An important application of CRISPR interference (CRISPRi) technology is for identifying chemical-genetic interactions (CGIs). Discovery of genes that interact with exposure to antibiotics can yield insights to drug targets and mechanisms of action or resistance. The objective is to identify CRISPRi mutants whose relative abundance is suppressed (or enriched) in the presence of a drug when the target protein is depleted, reflecting synergistic behavior. Different sgRNAs for a given target can induce a wide range of protein depletion and differential effects on growth rate. The effect of sgRNA strength can be partially predicted based on sequence features. However, the actual growth phenotype depends on the sensitivity of cells to depletion of the target protein. For essential genes, sgRNA efficiency can be empirically measured by quantifying effects on growth rate. We observe that the most efficient sgRNAs are not always optimal for detecting synergies with drugs. sgRNA efficiency interacts in a non-linear way with drug sensitivity, producing an effect where the concentration-dependence is maximized for sgRNAs of intermediate strength (and less so for sgRNAs that induce too much or too little target depletion). To capture this interaction, we propose a novel statistical method called CRISPRi-DR (for Dose-Response model) that incorporates both sgRNA efficiencies and drug concentrations in a modified dose-response equation. We use CRISPRi-DR to re-analyze data from a recent CGI experiment in Mycobacterium tuberculosis to identify genes that interact with antibiotics. This approach can be generalized to non-CGI datasets, which we show via an CRISPRi dataset for E. coli growth on different carbon sources. The performance is competitive with the best of several related analytical methods. However, for noisier datasets, some of these methods generate far more significant interactions, likely including many false positives, whereas CRISPRi-DR maintains higher precision, which we observed in both empirical and simulated data. |
| format | Article |
| id | doaj-art-22ac04704c36435b8f988a2b75a6c6b9 |
| institution | Kabale University |
| issn | 1553-734X 1553-7358 |
| language | English |
| publishDate | 2024-05-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Computational Biology |
| spelling | doaj-art-22ac04704c36435b8f988a2b75a6c6b92024-12-11T05:31:03ZengPublic Library of Science (PLoS)PLoS Computational Biology1553-734X1553-73582024-05-01205e101140810.1371/journal.pcbi.1011408A dose-response model for statistical analysis of chemical genetic interactions in CRISPRi screens.Sanjeevani ChoudheryMichael A DeJesusAarthi SrinivasanJeremy RockDirk SchnappingerThomas R IoergerAn important application of CRISPR interference (CRISPRi) technology is for identifying chemical-genetic interactions (CGIs). Discovery of genes that interact with exposure to antibiotics can yield insights to drug targets and mechanisms of action or resistance. The objective is to identify CRISPRi mutants whose relative abundance is suppressed (or enriched) in the presence of a drug when the target protein is depleted, reflecting synergistic behavior. Different sgRNAs for a given target can induce a wide range of protein depletion and differential effects on growth rate. The effect of sgRNA strength can be partially predicted based on sequence features. However, the actual growth phenotype depends on the sensitivity of cells to depletion of the target protein. For essential genes, sgRNA efficiency can be empirically measured by quantifying effects on growth rate. We observe that the most efficient sgRNAs are not always optimal for detecting synergies with drugs. sgRNA efficiency interacts in a non-linear way with drug sensitivity, producing an effect where the concentration-dependence is maximized for sgRNAs of intermediate strength (and less so for sgRNAs that induce too much or too little target depletion). To capture this interaction, we propose a novel statistical method called CRISPRi-DR (for Dose-Response model) that incorporates both sgRNA efficiencies and drug concentrations in a modified dose-response equation. We use CRISPRi-DR to re-analyze data from a recent CGI experiment in Mycobacterium tuberculosis to identify genes that interact with antibiotics. This approach can be generalized to non-CGI datasets, which we show via an CRISPRi dataset for E. coli growth on different carbon sources. The performance is competitive with the best of several related analytical methods. However, for noisier datasets, some of these methods generate far more significant interactions, likely including many false positives, whereas CRISPRi-DR maintains higher precision, which we observed in both empirical and simulated data.https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1011408&type=printable |
| spellingShingle | Sanjeevani Choudhery Michael A DeJesus Aarthi Srinivasan Jeremy Rock Dirk Schnappinger Thomas R Ioerger A dose-response model for statistical analysis of chemical genetic interactions in CRISPRi screens. PLoS Computational Biology |
| title | A dose-response model for statistical analysis of chemical genetic interactions in CRISPRi screens. |
| title_full | A dose-response model for statistical analysis of chemical genetic interactions in CRISPRi screens. |
| title_fullStr | A dose-response model for statistical analysis of chemical genetic interactions in CRISPRi screens. |
| title_full_unstemmed | A dose-response model for statistical analysis of chemical genetic interactions in CRISPRi screens. |
| title_short | A dose-response model for statistical analysis of chemical genetic interactions in CRISPRi screens. |
| title_sort | dose response model for statistical analysis of chemical genetic interactions in crispri screens |
| url | https://journals.plos.org/ploscompbiol/article/file?id=10.1371/journal.pcbi.1011408&type=printable |
| work_keys_str_mv | AT sanjeevanichoudhery adoseresponsemodelforstatisticalanalysisofchemicalgeneticinteractionsincrispriscreens AT michaeladejesus adoseresponsemodelforstatisticalanalysisofchemicalgeneticinteractionsincrispriscreens AT aarthisrinivasan adoseresponsemodelforstatisticalanalysisofchemicalgeneticinteractionsincrispriscreens AT jeremyrock adoseresponsemodelforstatisticalanalysisofchemicalgeneticinteractionsincrispriscreens AT dirkschnappinger adoseresponsemodelforstatisticalanalysisofchemicalgeneticinteractionsincrispriscreens AT thomasrioerger adoseresponsemodelforstatisticalanalysisofchemicalgeneticinteractionsincrispriscreens AT sanjeevanichoudhery doseresponsemodelforstatisticalanalysisofchemicalgeneticinteractionsincrispriscreens AT michaeladejesus doseresponsemodelforstatisticalanalysisofchemicalgeneticinteractionsincrispriscreens AT aarthisrinivasan doseresponsemodelforstatisticalanalysisofchemicalgeneticinteractionsincrispriscreens AT jeremyrock doseresponsemodelforstatisticalanalysisofchemicalgeneticinteractionsincrispriscreens AT dirkschnappinger doseresponsemodelforstatisticalanalysisofchemicalgeneticinteractionsincrispriscreens AT thomasrioerger doseresponsemodelforstatisticalanalysisofchemicalgeneticinteractionsincrispriscreens |